View Full Image The pricing policy has two aspects: the price paid to acquire the doses and the price charged to consumersUnfortunately, the whole vaccine ecosystem is messed up at the moment. In fact, till very recently the government had only put in orders for 100 million doses of Covishield, the vaccine that was supposed to be the workhorse of India’s vaccination programme. Since then it has added another order of 110 million doses of Covishield. Bharat Biotech’s annual production capacity is even lower at around 150 million doses. Since the vaccine supplier is neither consolidating public health information, nor accountable to the public, this has the recipe of a complete disaster in vaccine allocation.

Source: Mint May 06, 2021 15:53 UTC